Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Muscular dystrophies with reduced glycosylation of alpha-dystroglycan (alpha-DG), commonly referred to as dystroglycanopathies, are a heterogeneous group of autosomal recessive conditions which include a wide spectrum of clinical severity. Reported phenotypes range from severe congenital onset Walker-Warburg syndrome (WWS) with severe structural brain and eye involvement, to relatively mild adult onset limb girdle muscular dystrophy (LGMD). Specific clinical syndromes were originally described in association with mutations in any one of six demonstrated or putative glycosyltransferases. Work performed on patients with mutations in the FKRP gene has identified that the spectrum of phenotypes due to mutations in this gene is much wider than originally assumed. To further define the mutation frequency and phenotypes associated with mutations in the other five genes, we studied a large cohort of patients with evidence of a dystroglycanopathy. Exclusion of mutations in FKRP was a prerequisite for participation in this study. Ninety-two probands were screened for mutations in POMT1, POMT2, POMGnT1, fukutin and LARGE. Homozygous and compound heterozygous mutations were detected in a total of 31 probands (34 individuals from 31 families); 37 different mutations were identified, of which 32 were novel. Mutations in POMT2 were the most prevalent in our cohort with nine cases, followed by POMT1 with eight cases, POMGnT1 with seven cases, fukutin with six cases and LARGE with only a single case. All patients with POMT1 and POMT2 mutations had evidence of either structural or functional central nervous system involvement including four patients with mental retardation and a LGMD phenotype. In contrast mutations in fukutin and POMGnT1 were detected in four patients with LGMD and no evidence of brain involvement. The majority of patients (six out of nine) with mutations in POMT2 had a Muscle-Eye-Brain (MEB)-like condition. In addition we identified a mutation in the gene LARGE in a patient with WWS. Our data expands the clinical phenotypes associated with POMT1, POMT2, POMGnT1, fukutin and LARGE mutations. Mutations in these five glycosyltransferase genes were detected in 34% of patients indicating that, after the exclusion of FKRP, the majority of patients with a dystroglycanopathy harbour mutations in novel genes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A child affected with ASD and moderate intellectual disability was found to have a homozygous missense change (p.R367H) in POMGNT1 (Table 1B; Figure S4). POMGNT1 is responsible for an inherited dystroglycanopathy characterized by brain malformation, intellectual disability, developmental delay, hypotonia, and myopia; interestingly, rare patients have been reported with severe autistic features (”
From Using Whole-Exome Sequencing to Identify Inherited Causes of Autism (2013) · cites this paper as Godfrey et al., 2007
Citations
Cites
Muscle Biopsy: A Practical Approach
Dubowitz, V., Sewry, C. A., Oldfors, A., & Lane, R. J. M. (2020) · Cited by 1,335
Self-citationAn ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
Kobayashi, K., Nakahori, Y., Miyake, M., Matsumura, K., Kondo-Iida, E., Nomura, Y., Segawa, M., Yoshioka, M., Saito, K., Osawa, M., et al. (1998) · Nature · doi:10.1038/28653 · Cited by 802
Yoshida, A., Kobayashi, K., Manya, H., Taniguchi, K., Kano, H., Mizuno, M., Inazu, T., Mitsuhashi, H., Takahashi, S., Takeuchi, M., et al. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00070-3 · Cited by 706 · cited 2×
“These genes are thought to be involved in the addition of carbohydrate residues onto the -DG backbone either via the process of O-mannosylation (POMT1, POMT2, POMGnT1) (Yoshida et al., 2001; Manya et al., 2003; Akasaka-Manya et al., 2004) or via other not fully characterized mechanisms (fukutin, FKRP and LARGE) (de Pa…”
BackgroundSelf-citationBeltrán-Valero de Bernabé, D., Currier, S., Steinbrecher, A., Celli, J., van Beusekom, E., van der Zwaag, B., Kayserili, H., Merlini, L., Chitayat, D., Dobyns, W. B., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342975 · Cited by 685
Brockington, M., Blake, D. J., Prandini, P., Brown, S. C., Torelli, S., Benson, M. A., Ponting, C. P., Estournet, B., Romero, N. B., Mercuri, E., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/324412 · Cited by 603
Self-citationDystroglycan: from biosynthesis to pathogenesis of human disease
Barresi, R., & Campbell, K. P. (2006) · Journal of Cell Science · doi:10.1242/jcs.02814 · Cited by 596
Williamson, R. A., Henry, M. D., Daniels, K. J., Hrstka, R. F., Lee, J. C., Sunada, Y., Ibraghimov-Beskrovnaya, O., & Campbell, K. P. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.6.831 · Cited by 541
Brockington, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.25.2851 · Cited by 499
Self-citationLongman, C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg307 · Cited by 416
Self-citationPOMT2 mutations cause α-dystroglycan hypoglycosylation and Walker-Warburg syndrome
van Reeuwijk, J., Janssen, M., van den Elzen, C., Beltran-Valero de Bernabé, D., Sabatelli, P., Merlini, L., Boon, M., Scheffer, H., Brockington, M., Muntoni, F., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.031963 · Cited by 414
Self-citation
Cited by
Items 201–300 of 465
TMEM5-associated dystroglycanopathy presenting with CMD and mild limb-girdle muscle involvement
Astrea, G., Pezzini, I., Picillo, E., Pasquariello, R., Moro, F., Ergoli, M., D′Ambrosio, P., D’Amico, A., Politano, L., & Santorelli, F. M. (2016) · Neuromuscular Disorders · doi:10.1016/j.nmd.2016.05.003 · Cited by 16
Gumlaw, N., Sevigny, L. M., Zhao, H., Luo, Z., Bangari, D. S., Masterjohn, E., Chen, Y., McDonald, B., Magnay, M., Travaline, T. L., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.11.023 · Cited by 16
Guimaraes, C. V. A., & Dahmoush, H. (2020) · Pediatric Radiology · doi:10.1007/s00247-020-04674-5 · Cited by 16
Lim, B. C., Lee, S., Shin, J.-Y., Hwang, H. Y., Kim, K. J., Hwang, Y. S., Seo, J., Kim, J., & Chae, J. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.01.007 · Cited by 16
Congenital mirror movements in a patient with alpha-dystroglycanopathy due to a novel POMK mutation
Ardıçlı, D., Göçmen, R., Talim, B., Sprute, R., Haliloğlu, G., Çırak, S., & Topaloğlu, H. (2016) · Neuromuscular Disorders · doi:10.1016/j.nmd.2016.12.008 · Cited by 16
Self-citationMaroofian, R., Riemersma, M., Jae, L. T., Zhianabed, N., Willemsen, M. H., Wissink-Lindhout, W. M., Willemsen, M. A. A. P., de Brouwer, A. P. M., Mehrjardi, M. Y. V., Ashrafi, M. R., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0505-2 · Cited by 16
Leibovitz, Z., Mandel, H., Falik‐Zaccai, T. C., Harouch, S. B., Savitzki, D., Haratz, K. K., Gindes, L., Tamarkin, M., Lev, D., Dobyns, W. B., et al. (2017) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2017.12.012 · Cited by 16
Intragenic rearrangements in LARGE and POMGNT1 genes in severe dystroglycanopathies
Vuillaumier‐Barrot, S., Bouchet-Séraphin, C., Chelbi, M., Caye‐Eude, A., Charluteau, E., Besson, C., Quentin, S., Devisme, L., Bizec, C. L., Landrieu, P., et al. (2011) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.06.001 · Cited by 16
Talenti, G., Robson, C. D., Severino, M., Alves, C., Chitayat, D. A., Dahmoush, H., Smith, L., Muntoni, F., Blasér, S., & D’Arco, F. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6858 · Cited by 15
Self-citationBausewein, D., Engel, J., Jank, T., Schoedl, M., & Strahl, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.739128 · Cited by 15
Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy
Sciandra, F., Bigotti, M. G., Giardina, B., Bozzi, M., & Brancaccio, A. (2015) · BioMed Research International · doi:10.1155/2015/635792 · Cited by 15
Novel POMGnT1 mutations cause muscle-eye-brain disease in Chinese patients
Jiao, H., Manya, H., Wang, S., Zhang, Y., Li, X., Xiao, J., Yang, Y., Kobayashi, K., Toda, T., Endo, T., et al. (2013) · Molecular Genetics and Genomics · doi:10.1007/s00438-013-0749-5 · Cited by 15
ISPD mutations account for a small proportion of Italian Limb Girdle Muscular Dystrophy cases
Magri, F., Colombo, I., Bo, R. D., Previtali, S. C., Brusa, R., Ciscato, P., Scarlato, M., Ronchi, D., D’Angelo, M. G., Corti, S. P., et al. (2015) · BMC Neurology · doi:10.1186/s12883-015-0428-8 · Cited by 15
Amato, A. A., & Brooke, M. H. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7506-7525-3.50121-7 · Cited by 15
Kim, H., Moon, H. Y., Lee, D.-J., Cheon, S. A., Yoo, S. J., Park, J., Agaphonov, M. O., Oh, D., Kwon, O., & Kang, H. A. (2013) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2013.08.003 · Cited by 14
Kondakova, O. B., Yurievna, K. A., Tsukanov, K., Klimchuk, O. I., Korostin, D. O., Igorevna, D. A., Batysheva, T. T., Vyacheslavovna, Z. N., Surkova, E. I., Shatalov, P. A., et al. (2019) · BMC Pediatrics · doi:10.1186/s12887-019-1470-2 · Cited by 14
Genetic Diseases Associated with Protein Glycosylation Disorders in Mammals
Nakayama, Y., Nakamura, N., Tsuji, D., Ito, K., & Kurosak, A. (2013) · InTech eBooks · doi:10.5772/54097 · Cited by 15
A novel POMT2 mutation causes mild congenital muscular dystrophy with normal brain MRI
Murakami, T., Hayashi, Y. K., Ogawa, M., Noguchi, S., Campbell, K. P., Togawa, M., Inoue, T., Oka, A., Ohno, K., Nonaka, I., et al. (2008) · Brain and Development · doi:10.1016/j.braindev.2008.08.005 · Cited by 14
Mouse Forward Genetics in the Study of the Peripheral Nervous System and Human Peripheral Neuropathy
Douglas, D. S., & Popko, B. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9719-4 · Cited by 14
Cotarelo, R. P., Fano, O., Raducu, M., Peña, A., Tarilonte, P., Mateos, F., Simón, R., Cabello, A., & Cruces, J. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01188.x · Cited by 14
Brown, S., & Winder, S. J. (2012) · Neuromuscular Disorders · doi:10.1016/j.nmd.2012.02.006 · Cited by 13
Self-citationTowards Central Nervous System Involvement in Adults with Hereditary Myopathies
Reimann, J., & Kornblum, C. (2020) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-200507 · Cited by 13
Identification and Modeling of a GT-A Fold in the α-Dystroglycan Glycosylating Enzyme LARGE1
Righino, B., Bozzi, M., Pirolli, D., Sciandra, F., Bigotti, M. G., Brancaccio, A., & Rosa, M. C. D. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00281 · Cited by 13
Kim, H., Thak, E. J., Lee, D.-J., Agaphonov, M. O., & Kang, H. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129914 · Cited by 13
Inhibitory CCK+ basket synapse defects in mouse models of dystroglycanopathy
Jahncke, J. N., Miller, D. S., Krush, M., Schnell, E., & Wright, K. M. (2024) · eLife · doi:10.7554/elife.87965 · Cited by 12
Haro, C., Uribe, M. L., Quereda, C., Cruces, J., & Martín‐Nieto, J. (2018) · PubMed · Cited by 12
Holman, N., Wilkinson, A. J., & Smith, M. C. M. (2021) · Microbiology · doi:10.1099/mic.0.001103 · Cited by 12
A novel homozygous ISPD gene mutation causing phenotype variability in a consanguineous family
Baranello, G., Saredi, S., Sansanelli, S., Savadori, P., Canioni, E., Chiapparini, L., Balestri, P., Malandrini, A., Arnoldi, M. T., Pantaleoni, C., et al. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.08.007 · Cited by 12
Yu, Q., Morales, M., Li, N., Fritz, A. G., Ren, R., Blaeser, A., Francois, E., Lu, Q., Nagaraju, K., & Spurney, C. F. (2018) · Skeletal Muscle · doi:10.1186/s13395-018-0158-x · Cited by 12
Illness-associated muscle weakness in dystroglycanopathies
Carlson, C. R., McGaughey, S., Eskuri, J. M., Stephan, C. M., Zimmerman, M. B., & Mathews, K. D. (2017) · Neurology · doi:10.1212/wnl.0000000000004720 · Cited by 11
Pestronk, A. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz111 · Cited by 11
Muntoni, F., Guicheney, P., & Voït, T. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.11.008 · Cited by 11
Self-citationNarayanaswami, P., Carter, G., David, W., Weiß, M., & Amato, A. A. (2015) · PubMed · Cited by 11
Chen, Y.-W., Bittel, A. J., Bittel, D. C., Moon, Y. J., McCormack, N. M., & Jaiswal, J. K. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-88361-3_11 · Cited by 10
Sarcotubular Myopathy Due to Novel TRIM32 Mutation in Association with Multiple Sclerosis
Marchuk, M., DOVBONOS, T. A., Makukh, H., Semeryak, O., & Sharhorodska, Y. (2021) · Brain Sciences · doi:10.3390/brainsci11081020 · Cited by 10
Traverso, M., Baratto, S., Iacomino, M., Duca, M. D., Panicucci, C., Casalini, S., Grandis, M., Falace, A., Torella, A., Picillo, E., et al. (2024) · European Journal of Human Genetics · doi:10.1038/s41431-023-01516-4 · Cited by 10
Malformations of Cortical Development
Dobyns, W. B., Leventer, R. J., & Guerrini, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-37101-8.00029-1 · Cited by 10
Urologic and gastrointestinal symptoms in the dystroglycanopathies
Crockett, C. D., Bertrand, L. A., Cooper, C. S., Rahhal, R. M., Liu, K., Zimmerman, M. B., Moore, S. A., & Mathews, K. D. (2015) · Neurology · doi:10.1212/wnl.0000000000001213 · Cited by 10
Raducu, M., Cotarelo, R. P., Simón, R., Camacho, A., Rubio‐Fernández, M., Hernández‐Laín, A., & Cruces, J. (2013) · Journal of Child Neurology · doi:10.1177/0883073813509119 · Cited by 10
Muscular dystrophy-dystroglycanopathy in a family of Labrador retrievers with a LARGE1 mutation
Shelton, G. D., Minor, K. M., Guo, L. T., Friedenberg, S. G., Cullen, J. N., Hord, J. M., Venzke, D. P., Anderson, M. E., Devereaux, M., Prouty, S. J., et al. (2021) · Neuromuscular Disorders · doi:10.1016/j.nmd.2021.07.016 · Cited by 10
Saredi, S., Ruggieri, A., Mottarelli, E., Ardissone, A., Zanotti, S., Farina, L., Morandi, L. O., Mora, M., & Moroni, I. (2009) · Muscle & Nerve · doi:10.1002/mus.21271 · Cited by 10
Pattern recognition on brain magnetic resonance imaging in alpha dystroglycanopathies
Taly, A., Sankaran, B. P., Gayathri, N., Bharath, R., Mahadevan, A., & Sinha, S. (2010) · Neurology India · doi:10.4103/0028-3886.65925 · Cited by 10
Villar‐Quiles, R. N., Hayes, L. H., Raga, S. V., Bönnemann, C. G., Oates, E. C., Dowling, J. J., Ferreiro, A., Agrawal, P., Beggs, A. H., Davis, M., et al. (2025) · Neuromuscular Disorders · doi:10.1016/j.nmd.2025.106328 · Cited by 9
Self-citationVannoy, C. H., Zhou, H., Qiao, C., Xiao, X., Bang, A. G., & Lu, Q. L. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.09.024 · Cited by 9
Development and Developmental Disorders of the Cerebral Cortex
ten Donkelaar, H. J., Lammens, M. M. Y., Aronica, E., van Bokhoven, H., Ulzen, K. K.-V., & Hori, A. (2014) · Springer eBooks · doi:10.1007/978-3-642-54687-7_10 · Cited by 9
Muscle Involvement and Restricted Disorders
Darras, B. T., & Volpe, J. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42876-7.00033-8 · Cited by 9
The 2010 version of the gene table of neuromuscular disorders
(2010) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.11.012 · Cited by 9
Homozygous Fukutin Missense Mutation in Two Mexican Siblings with Dilated Cardiomyopathy
Villarreal-Molina, M. T., Rosas‐Madrigal, S., Mora, E. L., Calderón-Avila, A. L., Rodríguez‐Zanella, H., Romero‐Hidalgo, S., Rosendo‐Gutiérrez, R., & Carnevale, A. (2020) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.20000277 · Cited by 9
Uribe, M. L., Martín‐Nieto, J., Quereda, C., Rubio‐Fernández, M., Cruces, J., Janssen, G. M. C., de Ru, A. H., van Veelen, P. A., & Hensbergen, P. J. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00126 · Cited by 9
Wong, W., Estep, J. A., Treptow, A. M., Rajabli, N., Jahncke, J. N., Ubina, T., Wright, K. M., & Riccomagno, M. M. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002212 · Cited by 9
Hereditary and Acquired Myopathies
Salih, M. A. M., & Kang, P. B. (2020) · Springer eBooks · doi:10.1007/978-3-319-43153-6_43 · Cited by 9
An integrated approach to the diagnosis of muscle disorders: what is the role of muscle imaging?
Mercuri, E. M. (2010) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2010.03726.x · Cited by 9
Self-citationDiagnostic dilemma's: The congenital disorders of glycosylation are clinical chameleons
Coman, D. J. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201962 · Cited by 9
Pezzoni, L., Brusa, R., Difonzo, T., Magri, F., Velardo, D., Corti, S. P., Comi, G. P., & Saetti, M. C. (2023) · Neurological Sciences · doi:10.1007/s10072-023-07169-x · Cited by 8
Karas, B. F., Terez, K. R., Mowla, S., Battula, N., Flannery, K. P., Gural, B. M., Aboussleman, G., Mubin, N., & Manzini, M. C. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae006 · Cited by 8
Prenatal diagnosis of Walker–Warburg syndrome due to compound mutations in the B3GALNT2 gene
Wang, P., Jin, P., Zhu, L., Chen, M., Qian, Y., Zeng, W., Wang, M., Xu, Y., Xu, Y., & Dong, M. (2022) · The Journal of Gene Medicine · doi:10.1002/jgm.3417 · Cited by 8
Hereditary and Acquired Myopathies
Salih, M. A. M. (2012) · Springer eBooks · doi:10.1007/978-3-642-02202-9_374 · Cited by 8
Limb-girdle Muscular Dystrophies
Mohassel, P., & Bönnemann, C. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417044-5.00034-2 · Cited by 8
Stavusis, J., Mičule, I., Wright, N. T., Straub, V. W., Töpf, A., Oliveira, L. P., Domínguez‐González, C., Inashkina, I., Kidere, D., Chrestian, N., et al. (2020) · Neuromuscular Disorders · doi:10.1016/j.nmd.2020.03.010 · Cited by 8
Self-citationPhenotype and Genotype Study of Chinese POMT2-Related α-Dystroglycanopathy
Chen, X.-Y., Song, D., Jiang, L., Tan, D., Liu, Y., Liu, J., Chang, X., Xing, G., Toda, T., & Xiong, H. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.692479 · Cited by 8
Founder mutation causes classical Fukuyama congenital muscular dystrophy (FCMD) in Chinese patients
Yang, H., Kobayashi, K., Wang, S., Jiao, H., Xiao, J., Toda, T., Wu, X., & Xiong, H. (2015) · Brain and Development · doi:10.1016/j.braindev.2015.02.010 · Cited by 8
Traversa, A., Bernardo, S., Paiardini, A., Giovannetti, A., Marchionni, E., Genovesi, M. L., Guadagnolo, D., Torres, B., Paolacci, S., Bernardini, L., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1054 · Cited by 7
Brown, S., Fernández-Fuente, M., Muntoni, F., & Vissing, J. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa120 · Cited by 7
Self-citationPrenatal presentation of Walker–Warburg syndrome with a POMT2 mutation: an extended fetal phenotype
El‐Dessouky, S. H., Hosny, H., Elarab, A. E., & Issa, M. Y. (2020) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-020-00093-1 · Cited by 7
Lynch, T., Lam, L. T., Mân, N. T., Kobayashi, K., Toda, T., & Morris, G. E. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.147 · Cited by 7
Simmons, Z. (2008) · Journal of Clinical Neuromuscular Disease · doi:10.1097/cnd.0b013e3181659999 · Cited by 7
Prenatal muscle development in a mouse model for the secondary dystroglycanopathies
Kim, J., Hopkinson, M., Kavishwar, M., Fernández-Fuente, M., & Brown, S. (2015) · Skeletal Muscle · doi:10.1186/s13395-016-0073-y · Cited by 7
Self-citationAmato, A. A., & Brooke, M. H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0434-1.00104-3 · Cited by 7
Ismail, S. I., Schaffer, A. E., Rosti, R. Ö., Gleeson, J. G., & Zaki, M. S. (2014) · Gene · doi:10.1016/j.gene.2014.01.070 · Cited by 7
Biochemical and molecular basis of muscle disease
Brown, S., & Jimenez-Mallebrera, C. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511674747.007 · Cited by 7
Self-citationSchizophrenia and human self-domestication: an evolutionary linguistics approachPreprint
Benítez‐Burraco, A., Pietro, L. D., Barba, M., & Lattanzi, W. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/072751 · Cited by 7
Fujimoto, T., Mori, M., Tonosaki, M., Yaoi, T., Nakano, K., Okamura, T., & Itoh, K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-024-04676-6 · Cited by 6
Malformations of Core M3 on α-Dystroglycan Are the Leading Cause of Dystroglycanopathies
Sharaf‐Eldin, W. E. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02320-z · Cited by 6
UDP‐glucose dehydrogenase variants cause dystroglycanopathy
Reelfs, A. M., Stephan, C. M., Czech, T. M., Cox, M. O., Joseph, S., Darbro, B. W., Moore, S. A., Campbell, K. P., & Mathews, K. D. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70002 · Cited by 6
Dystroglycan Glycosylation and Its Involvement in Muscular Dystrophy
Kanagawa, M. (2014) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.26.41 · Cited by 6
Keeping an eye on congenital disorders of O-glycosylation: a systematic literature review
Francisco, R., Pascoal, C., Marques‐da‐Silva, D., Morava, É., Gole, G. A., Coman, D. J., Jaeken, J., & Ferreira, V. D. R. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-017-0119-2 · Cited by 6
Costa, C., Oliveira, J., Gonçalves, A., Santos, R., Bronze-da-Rocha, E., Rebelo, O., Pais, R. P. F., & Fineza, I. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.03.005 · Cited by 6
Serial prenatal and postnatal MRI of dystroglycanopathy in a patient with familial B3GALNT2 mutation
Ho, M., Glenn, O. A., Sherr, E. H., & Strober, J. B. (2017) · Pediatric Radiology · doi:10.1007/s00247-017-3821-1 · Cited by 6
Neonatal Neuromuscular Disorders
Natarajan, N., & Ionita, C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40139-5.00064-4 · Cited by 6
Ibrahim, R. S. M., & Hachem, R. H. (2020) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1186/s43055-020-00152-y · Cited by 6
Furey, C. G., Antwi, P., & Kahle, K. T. (2018) · Springer eBooks · doi:10.1007/978-3-319-97928-1_5 · Cited by 6
Chong, Y. K., Kwan, L. C., Lo, K. K. L., Lee, C. K. L., Mak, C. M., Kan, A., & Lam, C. W. (2014) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2014.03.003 · Cited by 6
Milder phenotype of congenital muscular dystrophy in a novel POMT1 mutation
Al-Zaidy, S. A., Baskin, B., Hawkins, C. E., Yoon, G., Ray, P. N., & Vajsar, J. (2011) · Muscle & Nerve · doi:10.1002/mus.23274 · Cited by 6
Muscular dystrophies presenting with proximal muscle weakness
Vainzof, M., & Bushby, K. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511674747.015 · Cited by 6
Self-citationSchmidtke, D., Lempp, C., Dubicanac, M., Radespiel, U., Zimmermann, E., Baumgärtner, W., Kästner, S., Meier, M., Balkema‐Buschmann, A., Harris, R. A., et al. (2018) · Comparative Medicine · doi:10.30802/aalas-cm-18-000019 · Cited by 6
Nairn, A. V., & Moremen, K. W. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-373600-0.00005-6 · Cited by 6
Fukuyama-type congenital muscular dystrophy and defective glycosylation of α-dystroglycan
Saito, F., & Matsumura, K. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-22 · Cited by 6
Abnormal glycosylation of the α-dystroglycan: Deficient sugars are no good
Topaloğlu, H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a4e451 · Cited by 6
Childhood muscular dystrophies
Younger, D. S. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98818-6.00024-8 · Cited by 5
Hopkinson, M., & Pitsillides, A. A. (2025) · International Journal of Experimental Pathology · doi:10.1111/iep.12525 · Cited by 5
Sirchia, F., Fantasia, I., Feresin, A., Giorgio, E., Faletra, F., Mordeglia, D., Barbieri, M., Guida, V., Luca, A. D., & Stampalija, T. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-00939-6 · Cited by 5
The spectrum of hereditary neuromuscular disorders in the Pakistani population
Akbar, F., Saleem, S. M., Khalid, E., Ibrahim, S. H., Afroze, B., Kirmani, S., & Khan, S. A. (2023) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63332 · Cited by 5
Safwat, S., Flannery, K. P., ElBeheiry, A. A., Mokhtar, M. M., Abdalla, E. M., & Manzini, M. C. (2024) · Neurogenetics · doi:10.1007/s10048-024-00745-z · Cited by 5
Chawla, T., Nashi, S., Baskar, D., Polavarapu, K., Vengalil, S., Bardhan, M., Preethish‐Kumar, V., Sukrutha, R., Unnikrishnan, G., Huddar, A., et al. (2024) · Neurogenetics · doi:10.1007/s10048-024-00776-6 · Cited by 5
Pathologies des muscles striés squelettiques
Guis, S., Krahn, M., Fernandez, C., Mattei, J. P., Lévy, N., & Bendahan, D. (2010) · EMC - Appareil locomoteur · doi:10.1016/s0246-0521(09)48914-9 · Cited by 5
Cubilla, M. A., Papazoglu, G. M., & Asteggiano, C. (2023) · Journal of Inborn Errors of Metabolism and Screening · doi:10.1590/2326-4594-jiems-2022-0005 · Cited by 5
Novel fukutin mutations in limb-girdle muscular dystrophy type 2M with childhood onset
Smogavec, M., Zschüntzsch, J., Kreß, W., Mohr, J., Hellen, P., Zoll, B., Pauli, S., & Schmidt, J. (2017) · Neurology Genetics · doi:10.1212/nxg.0000000000000167 · Cited by 5
Prenatal presentation of a rare genetic disorder: a clinical, autopsy and molecular correlation
Arora, V., Bijarnia‐Mahay, S., Kulshreshtra, S., Singh, K., Puri, R. D., & Verma, I. C. (2019) · Autopsy and Case Reports · doi:10.4322/acr.2019.124 · Cited by 5
Congenital protein hypoglycosylation diseases
Sparks, S. E. (2012) · The Application of Clinical Genetics · doi:10.2147/tacg.s18673 · Cited by 5
Zebrafish as a Model Organism for Research in Rare Genetic Neuromuscular Diseases
Akyürek, E. E., Erba, M., Barba, F. D., Sandonà, D., & Sacchetto, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188832 · Cited by 4
Metadata
- Authors
- Godfrey, C., Clement, E., Mein, R., Brockington, M., Smith, J., Talim, B., Straub, V., Robb, S., Quinlivan, R., Feng, L., Jimenez-Mallebrera, C., Mercuri, E., Manzur, A. Y., Kinali, M., Torelli, S., Brown, S. C., Sewry, C. A., Bushby, K., Topaloglu, H., North, K., Abbs, S., & Muntoni, F.
- Affiliations
- The University of Sydney (AU)
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-10-01
- Volume
- 130
- Issue
- 10
- Pages
- 2725-2735
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2128173275
- Cited by
- 441
- References
- 35
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 13 · 2023: 21 · 2022: 13 · 2021: 24 · 2020: 23 · 2019: 21 · 2018: 23 · 2017: 21 · 2016: 22 · 2015: 24 · 2014: 33 · 2013: 34 · 2012: 35
- FWCI
- 11.12
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- dystroglycanopathies, alpha-dystroglycan glycosylation, genotype-phenotype correlation, POMT1, POMT2, POMGnT1, fukutin, LARGE, limb-girdle muscular dystrophy, Walker-Warburg syndrome, compound heterozygosity
- MeSH terms
- Child, Preschool, DNA Mutational Analysis, Glycosylation, Humans, Infant, Male, Mannosyltransferases, Membrane Proteins, Muscular Dystrophies, Mutation, Phenotype, Cohort Studies, N-Acetylglucosaminyltransferases, Dystroglycans, Muscular Dystrophies, Limb-Girdle
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.